|
|
Article: Acologix Hopes To Bring In $115M On Tokyo Exchange.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
With Japanese investors holding the majority of its shares and a lead product in-licensed from a Tokyo-based company, Acologix Inc. filed to conduct a $115 million initial public offering on the Tokyo Stock Exchange.
The Hayward, Calif.-based company is one of a handful of American firms this year that have turned to more receptive foreign markets to go public. In July, South San Francisco-based Napo Pharmaceuticals Inc. completed a $22 million IPO on the London Stock Exchange, and a month earlier, PuriCore Inc., of Malvern, Pa., through its parent company, PuriCore plc, raised $54.7 million through a London IPO.
If Acologix ...